Director, PDM Business Process & Operational Excellence - Foster City at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, Pharmaceutical DevelopmentIndustries

Requirements

A degree in life sciences or a relevant business area with 12+ years of varied post-graduation experience in Pharmaceuticals, Biosciences or a related industry
Or MS with 10+ years of relevant experience
Or PhD with 8+ years of relevant experience

Responsibilities

Lead cross-functional business process mapping and OpEx initiatives, utilizing exceptional facilitation skills to gather SME input and design clear end-to-end business processes that improve current processes, with expertise in business process and OpEx methodologies and tools
Analyze situations and/or data, applying sound judgment and reasoning, to identify and resolve problems and make recommendations for high impact processes across multiple PDM functions
Ensure initiatives are set for success to deliver on time and within budget with appropriate stakeholder management
Proactively identify and drive continuous improvement and innovation opportunities across PDM
Interface with members of the PDM Extended Leadership Team to drive meaningful process improvements in PDM
Utilize excellent analytical, communication and influencing skills, as well as a keen problem-solving ability, to drive helpful change and continuous improvement
Mentor and influence PDM lean enthusiasts as a trainer for lean methodologies and member of the wider PDM Operational Excellence community

Skills

Business Process Improvement

Operational Excellence

Lean

Six Sigma

Process Optimization

Pharmaceutical Manufacturing

Leadership

Cross-functional Collaboration

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free